WASHINGTON (Reuters) - The U.S. Supreme Court ruled on Monday that the Federal Trade Commission can challenge deals that brand-name drug companies make with generic rivals to keep cheaper products ...
Read more
DUBAI (Reuters) - Four more people have died and three more have fallen ill in Saudi Arabia from the new SARS-like coronavirus MERS-CoV, the Saudi Health Ministry said on Monday.The ...
Read more
ZURICH (Reuters) - Japan's health ministry has approved drug Avastin for the treatment of aggressive brain cancer in Japan, Swiss pharmaceuticals company Roche said on Monday.Avastin is the first new ...
Read more
LONDON (Reuters) - British scientists have won early financial backing for a new kind of anticoagulant drug they believe may prevent dangerous blood clots without causing bleeding - a previously ...
Read more
WASHINGTON, June 14 (Reuters) - In the final months leading up to the launch of the key piece of President Barack Obama's healthcare reforms, the administration is preparing a public-education ...
Read more
RIYADH (Reuters) - One more person has died and two more have fallen ill in Saudi Arabia from the new SARS-like coronavirus, MERS-CoV, the Saudi Health Ministry said on Friday.Saudi ...
Read more
MUMBAI (Reuters) - Ranbaxy Laboratories, India's No.1 drugmaker by sales, plans to file three to four generic drug applications every year that can earn it a six-month marketing exclusivity in ...
Read more
"Bloomberg" reports that Paris prosecutors have opened an investigation into drug packaging mistakes at a Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) plant in Sens, in north-central France, which ...
Read more
Based on these studies, "it's very difficult to make definitive statements on efficacy," said Dr. Raphael Leo, the study's author from the State University of New York at Buffalo. "Certainly, ...
Read more
LONDON (Reuters) - Europe's drugs agency warned on Friday that use of the common painkiller diclofenac, especially in high doses, carries extra heart attack risks which should be taken into ...
Read more
LONDON (Reuters) - British drugmaker AstraZeneca is deepening its collaboration with academia by roping in more outside researchers to help to find new cancer drugs.Scientists at the Cancer Research UK ...
Read more
(Reuters) - Eli Lilly and Co said on Thursday it was halting a midstage clinical trial of an experimental Alzheimer's disease treatment due to potential liver toxicity problems.It was the ...
Read more
WASHINGTON, June 13 (Reuters) - The U.S. Supreme Court on Thursday issued a mixed ruling in a case concerning patents held by Myriad Genetics Inc over the closely watched issue ...
Read more
(Reuters) - Eli Lilly and Co and Incyte Corp said their experimental drug was effective in reducing painful symptoms associated with rheumatoid arthritis after 52 weeks of treatment.The drug, baricitinib, ...
Read more
LONDON (Reuters) - GlaxoSmithKline has finally won a green light from Britain's healthcare cost agency NICE for its platelet-boosting drug Revolade, after offering a price discount to the country's state-run ...
Read more
